Sumatriptan-naproxen and butalbital: A double-blind, placebo-controlled crossover study

Headache

Volumn 52, Issue 4, 2012, Pages 530-543

  Derosier, Frederick ^a   Sheftell, Fred ^b   Silberstein, Stephen ^c   Cady, Roger ^d   Ruoff, Gary ^e   Krishen, Alok ^a   Peykamian, Margaret ^a  

^a GLAXOSMITHKLINE   (United States)

^b NEW ENGLAND CENTER FOR HEADACHE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Banyan Group Inc Headache   (United States)

^e Westside Family Medical Center   (United States)

Author keywords

butalbital; Fioricet; migraine; sumatriptan naproxen combination

Indexed keywords

BUTALBITAL; CAFFEINE; NAPROXEN; PARACETAMOL; PLACEBO; SUMATRIPTAN;

ADULT; AGED; ANALGESIA; ARTICLE; BIOASSAY; BREAST CANCER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; OUTPATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; THORAX PAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BARBITURATES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NAPROXEN; SUMATRIPTAN; YOUNG ADULT;

EID: 84859732012     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.02039.x     Document Type: Article

References (19)

1. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Steward WF,. Migraine in the United States: Epidemiology and patterns of heath care use. Neurology. 2002; 58: 885-894.
2. Ito T, Suzuki T, Wellman SE, Ho IK,. Pharmacology of barbiturate tolerance/dependence: GABAa receptors and molecular aspects. Life Sci. 1996; 59: 169-195.
3. Wenzel RG, Sarvis CA,. Do butalbital-containing products have a role in the management of migraine. Pharmacotherapy. 2002; 22: 1029-1035.
4. Isbell H, Fraser HF,. Addiction to analgesics and barbiturates. J Pharmacol Exp Ther. 1950; 99: 355-397.
5. Loder E,. Fixed drug combinations for the acute treatment of migraine: Place in therapy. CNS Drugs. 2005; 19: 769-784.
6. Novartis Pharmaceuticals. Fioricet (Butalbital, Acetaminophen, Caffeine) Product Information. East Hanover, NJ: Novartis Pharmaceuticals; 2007.
7. Sellers EM,. Alcohol, barbiturates and benzodiazepine withdrawal syndromes: Clinical management. Can Med Assoc J. 1988; 139: 113-120.
8. Silberstein SD, McCrory DC,. Butalbital in the treatment of headache: History, pharmacology, and efficacy. Headache. 2001; 41: 953-967.
9. Bigal ME, Borucho S, Serrano D, Lipton RB,. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009; 29: 891-897.
10. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB,. Transformed migraine and medication overuse in a tertiary headache center-clinical characteristics and treatment outcomes. Cephalalgia. 2004; 24: 483-490.
11. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB,. Migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008; 48: 1157-1168.
12. Ferrone M, Motl SE,. Current pharmacotherapy for the treatment of migraine. US Pharm. 2003; 28: 1-26.
13. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC,. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002; 59: 1011-1014.
14. Snow V, Weiss K, Wall E, Mottur-Pilson C,. Pharmacological management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002; 137: 840-849.
15. Silberstein SD,. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000; 55: 754-762.
16. Schroeder BM,. Practice guidelines AAFP/ACP-ASIM release guidelines on the management and prevention of migraines. Am Fam Physician. 2003; 67: 1392-1397.
17. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF,. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache. 2001; 41: 638-645.
18. GlaxoSmithKline. Treximet (Sumatriptan and Naproxen Sodium) Product Information. Research Triangle Park, NC: GlaxoSmithKline; 2009.
19. Brandes JL, Kudrow D, Stark SR, et al,. Sumatriptan-naproxen for acute treatment of migraine: A randomized trial. JAMA. 2007; 297: 1443-1454.